Lethal graft-versus-host disease in congenital neutropenia caused by p14 deficiency after allogeneic bone marrow transplantation from an HLA-identical sibling

Pediatric Blood and Cancer

Volumn 51, Issue 3, 2008, Pages 436-438

  Bohn, Georg ^a   Hardtke Wolenski, Matthias ^a   Zeidler, Cornelia ^a   Maecker, Britta ^a   Sauer, Martin ^a   Sykora, Karl Walter ^a   Grigull, Lorenz ^a   Welte, Karl ^a   Klein, Christoph ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Congenital neutropenia; GvHD; HLA identical transplantation; Immunodeficiency; P14

Indexed keywords

ANTIBIOTIC AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FOSCARNET; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G; METHOTREXATE; MORPHINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PROTEIN P14; RIBAVIRIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW BIOPSY; BONE PAIN; CASE REPORT; CONTINUOUS INFUSION; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; DENDRITIC CELL; DISEASE SEVERITY; GRAFT VERSUS HOST REACTION; HEADACHE; HLA SYSTEM; HUMAN; HUMAN TISSUE; LOW DRUG DOSE; MALE; MYELOABLATIVE CONDITIONING; NEUTROPENIA; NEUTROPHIL COUNT; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAINFLUENZA VIRUS 3; PNEUMONIA; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RISK FACTOR; SIBLING;

BONE MARROW TRANSPLANTATION; CHILD; FATAL OUTCOME; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMANS; MALE; NEUTROPENIA; SIBLINGS; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 48249135487     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21643     Document Type: Article

References (20)

1. Teis D, Wunderlich W, Huber LA. Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction. Dev Cell 2002;3:803-814.
2. Teis D, Taub N, Kurzbauer R, et al. p14-MP1-MEK1 signaling regulates endosomal traffic and cellular proliferation during tissue homeostasis. J Cell Biol 2006;175:861-868.
3. Bohn G, Allroth A, Brandes G, et al. A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14. Nat Med 2007;13:38-45.
4. Dell'Angelica EC, Shotelersuk V, Aguilar RC, et al. Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the β3A subunit of the AP-3 adaptor. Mol Cell 1999;3:11-21.
5. Jung J, Bohn G, Allroth A, et al. Identification of a homozygous deletion in the AP3B1 gene causing Hermansky-Pudlak syndrome, type 2. Blood 2006;108:362-369.
6. Clark RH, Stinchcombe JC, Day A, et al. Adaptor protein 3-dependent microtubule-mediated movement of lytic granules to the immunological synapse. Nat Immunol 2003;4:1111-1120.
7. Ménasché G, Pastural E, Feldmann I, et al. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat Genet 2000;25:173-176.
8. Perou CM, Moore KJ, Nagle DL, et al. Identification of the murine beige gene by YAC complementation and positional cloning. Nat Genet 1996;13:303-308.
9. Nagle DL, Karim MA, Woolf EA, et al. Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nat Genet 1996;14:307-311.
10. Barbosa MDFS, Nguyen QA, Tchernev VT, et al. Identification of the homologous beige and Chediak-Higashi syndrome genes. Nature 1996;382:262-265.
11. Klein C, Philippe N, Le Deist F, et al. Partial albinism with immunodeficiency (Griscelli syndrome). J Pediatr 1994;125:886-895.
12. Haddad E, Le Deist F, Blanche S, et al. Treatment of Chediak-Higashi syndrome by allogenic bone marrow transplantation: report of 10 cases. Blood 1995;85:3328-3333.
13. Mottonen M, Lanning M, Saarinen UM. Allogeneic bone marrow transplantation in Chediak-Higashi syndrome. Pediatr Hematol Oncol 1995;12:55-59.
14. Klein C, Grudzien M, Appaswamy G, et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet 2007;39:86-92.
15. Benson KF, Li FQ, Person RE, et al. Mutations associated with neutropenia in dogs and humans disrupt intracellular transport of neutrophil elastase. Nat Genet 2003;35:90-96.
16. Holler E, Kolb HJ, Moller A, et al. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood 1990;75:1011-1016.
17. Matte CC, Liu J, Cormier J, et al. Donor APCs are required for maximal GVHD but not for GVL. Nat Med 2004;10:987-992.
18. Chakraverty R, Sykes M. The role of antigen-presenting cells in triggering GVHD and GVL. Blood 2007;110:9-17.
19. Holler E, Kolb HJ, Mittermuller J, et al. Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F).Blood 1995;86:890-899.
20. Peng JC, Hyde C, Pai S, et al. Monocyte-derived DC primed with TLR agonists secrete IL-12p70 in a CD40-dependent manner under hyperthermic conditions. J Immunother 2006;29:606-615.